ロード中...
An OPTIMIZE Study Retrospective Analysis for Management of Telaprevir-Treated Hepatitis C Virus (HCV)-Infected Patients by Use of the Abbott RealTime HCV RNA Assay
Protease inhibitor (PI)-based response-guided triple therapies for hepatitis C virus (HCV) infection are still widely used. Noncirrhotic treatment-naive and prior relapser patients receiving telaprevir-based treatment are eligible for shorter, 24-week total therapy if HCV RNA is undetectable at both...
保存先:
| 出版年: | J Clin Microbiol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4365219/ https://ncbi.nlm.nih.gov/pubmed/25653396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.03030-14 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|